The End of the LDT Battle
July 10, 2025
By Stephen Apfelroth
A landmark decision favors autonomy – but reignites the accountability conversation
2 min read
False
July 10, 2025
By Stephen Apfelroth
A landmark decision favors autonomy – but reignites the accountability conversation
2 min read
July 8, 2025
By Jessica Allerton
When traditional diagnostics fall short, biomarker testing offers respiratory relief in resource-limited settings
1 min read
July 1, 2025
By E. Blair Holladay
Overturned sweeping FDA regulations safeguarded access to essential diagnostics
2 min read
June 25, 2025
By Jennifer Hudson
Defining the roles of grossing personnel is crucial for maintaining diagnostic integrity and protecting patient outcomes
4 min read
May 19, 2025
By Jessica Allerton
As global health leaders reconsider how diagnostics are defined, pathologists are urged to contribute their insight and shape the future of the field
3 min read
May 16, 2025
By Caitlin Raymond
Rethinking the overturn of the FDA’s LDT rule
5 min read
April 1, 2025
By Helen Bristow
Federal Court decides FDA lacks the authority to regulate LDTs
2 min read
March 12, 2025
By Jessica Allerton
Harmonization and collaboration are key in advancing MRD testing, says Ramin Dowlati
3 min read
February 19, 2025
By Jessica Allerton
What does the US withdrawal from the World Health Organization mean for global health?
7 min read
February 17, 2025
By Stephanie Vine
Stakeholders explain why the NIH’s move to cap indirect costs associated with research grants could damage medical innovation.
4 min read
False
False
Dive deeper into the world of pathology. Explore the latest articles, case studies, expert insights, and groundbreaking research.
False